Anna Tasidou

777 total citations
13 papers, 375 citations indexed

About

Anna Tasidou is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Anna Tasidou has authored 13 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Genetics. Recurrent topics in Anna Tasidou's work include Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Anna Tasidou is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Anna Tasidou collaborates with scholars based in Greece. Anna Tasidou's co-authors include Efstathios Kastritis, Meletios Α. Dimopoulos, Maria Gavriatopoulou, Evangelos Terpos, Μαρία Ρούσσου, Stavroula Giannouli, Magdalini Migkou, Athanasios G. Tzioufas, Panayiotis D. Ziakas and Evangelos Eleftherakis-Papaiakovou and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Anna Tasidou

12 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Tasidou Greece	9	233	187	106	102	67	13	375
Ali Tabarroki United States	10	348 1.5×	448 2.4×	60 0.6×	225 2.2×	58 0.9×	27	679
Xianghua Huang China	10	180 0.8×	67 0.4×	51 0.5×	67 0.7×	61 0.9×	32	309
M Masi Italy	13	218 0.9×	458 2.4×	129 1.2×	105 1.0×	89 1.3×	26	597
Adrian Duek Israel	10	182 0.8×	241 1.3×	111 1.0×	201 2.0×	62 0.9×	34	397
Nikolaos Giannakoulas Greece	10	113 0.5×	184 1.0×	85 0.8×	77 0.8×	24 0.4×	27	323
MQ Lacy United States	11	347 1.5×	408 2.2×	229 2.2×	81 0.8×	13 0.2×	11	517
Chakra P. Chaulagain United States	10	182 0.8×	138 0.7×	107 1.0×	51 0.5×	10 0.1×	46	319
JM Hernández Spain	8	187 0.8×	346 1.9×	115 1.1×	100 1.0×	10 0.1×	12	426
Nicole Kucine United States	6	203 0.9×	140 0.7×	55 0.5×	142 1.4×	55 0.8×	25	386
Cesare Bergonzi Italy	9	175 0.8×	229 1.2×	124 1.2×	40 0.4×	11 0.2×	19	318

Countries citing papers authored by Anna Tasidou

Since Specialization

Citations

This map shows the geographic impact of Anna Tasidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tasidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tasidou more than expected).

Fields of papers citing papers by Anna Tasidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tasidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tasidou. The network helps show where Anna Tasidou may publish in the future.

Co-authorship network of co-authors of Anna Tasidou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tasidou. A scholar is included among the top collaborators of Anna Tasidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tasidou. Anna Tasidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kastritis, Efstathios, Maria Gavriatopoulou, Μαρία Ρούσσου, et al.. (2017). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy. American Journal of Hematology. 92(7). 632–639. 45 indexed citations

Kastritis, Efstathios, Maria Gavriatopoulou, Μαρία Ρούσσου, et al.. (2017). Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib. Blood Cancer Journal. 7(6). e570–e570. 30 indexed citations

Nikolaou, Vasiliki, Leonidas Marinos, Evangelia Papadavid, et al.. (2017). Psoriasis in patients with mycosis fungoides: a clinicopathological study of 25 patients. Journal of the European Academy of Dermatology and Venereology. 31(11). 1848–1852. 14 indexed citations

Kastritis, Efstathios, Maria Gavriatopoulou, Μαρία Ρούσσου, et al.. (2016). Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib. Blood. 128(22). 4500–4500.

Kastritis, Efstathios, Ioannis Papassotiriou, Evangelos Terpos, et al.. (2016). Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis. Blood. 128(3). 405–409. 36 indexed citations

Bagratuni, Tina, Evangelos Terpos, Evangelos Eleutherakis‐Papaiakovou, et al.. (2015). TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma. British Journal of Haematology. 172(1). 44–47. 8 indexed citations

Kastritis, Efstathios, Μαρία Ρούσσου, Maria Gavriatopoulou, et al.. (2015). Long‐term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. American Journal of Hematology. 90(4). E60–5. 35 indexed citations

Kastritis, Efstathios, Evangelos Terpos, Lia A. Moulopoulos, et al.. (2012). Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. Leukemia. 27(4). 947–953. 106 indexed citations

Tasidou, Anna, Μαρία Ρούσσου, Evangelos Terpos, et al.. (2012). Increased expression of cyclin‐D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents. American Journal of Hematology. 87(7). 734–736. 7 indexed citations

10.

Terpos, Evangelos, Anna Tasidou, Evangelos Eleftherakis-Papaiakovou, et al.. (2011). Expression of CCL3 by Neoplastic Cells in Patients with Waldenström's Macroglobulinemia: An Immunohistochemical Study in Bone Marrow Biopsies of 67 Patients. Clinical Lymphoma Myeloma & Leukemia. 11(1). 115–117. 5 indexed citations

11.

Terpos, Evangelos, Anna Tasidou, Efstathios Kastritis, et al.. (2009). Angiogenesis in Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 46–49. 9 indexed citations

12.

Voulgarelis, Michael, Stavroula Giannouli, Anna Tasidou, et al.. (2006). Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: A clinicopathological study. American Journal of Hematology. 81(8). 590–597. 51 indexed citations

13.

Ziakas, Panayiotis D., John G. Routsias, Stavroula Giannouli, et al.. (2006). Suspects in the tale of lupus-associated thrombocytopenia. Clinical & Experimental Immunology. 145(1). 71–80. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact